Glucotrack, Inc. Announces Reverse Stock SplitGlucotrack, Inc. (Nasdaq: GCTK) (Glucotrack or the Company), a healthcare technology and biopharmaceutical company operating Lkahi Therapeutics, today announced that it will effect a 1-for-2 reverse stock split (the Reverse Stock Split) of its issued and outstanding common stock, par value $0.001...